Emv Capital (EMVC) RNS Announcements

Add to Alert list
Date Time Source Announcement
07 Jun 2021 07:00 AM
RNS
ProAxsis Update
03 Jun 2021 04:30 PM
RNS
Result of AGM
03 Jun 2021 08:14 AM
RNS
Holding(s) in Company
28 May 2021 02:20 PM
RNS
Holding(s) in Company
27 May 2021 04:41 PM
RNS
Second Price Monitoring Extn
27 May 2021 04:36 PM
RNS
Price Monitoring Extension
24 May 2021 07:00 AM
RNS
ProAxsis Update
21 May 2021 11:00 AM
RNS
Price Monitoring Extension
20 May 2021 04:19 PM
RNS
PDS Announces Release of PDS0101 Abstract
20 May 2021 07:00 AM
RNS
EMV Capital Advises on £3.4m PointGrab Fundraise
18 May 2021 07:00 AM
RNS
PDS receives $4.5m from net sale of tax benefits
13 May 2021 03:15 PM
RNS
PDS Reports Results for Q1 2021 & Business Update
13 May 2021 07:00 AM
RNS
EMV Capital Advises on £2.9m SageTech Fundraise
30 Apr 2021 07:00 AM
RNS
PDS Announces Presentation at ASCO Annual Meeting
28 Apr 2021 10:08 AM
RNS
EMV Capital Advises on £740k Fundraise for Sofant
14 Apr 2021 02:25 PM
RNS
Notice of AGM and Annual Report & Accounts
31 Mar 2021 09:02 AM
RNS
Preliminary Results for the year ended 31 Dec 2020
30 Mar 2021 07:00 AM
RNS
Notice of Results & Investor Presentation
18 Mar 2021 11:48 AM
RNS
PDS Reports Results for FY2020 & Business Update
11 Mar 2021 03:26 PM
RNS
$60m Commitment for PDS Vaccine Consortium
23 Feb 2021 07:00 AM
RNS
PDS Biotech Consortium Update
22 Feb 2021 07:00 AM
RNS
ProAxsis Update
10 Feb 2021 11:01 AM
RNS
Price Monitoring Extension
10 Feb 2021 09:05 AM
RNS
Second Price Monitoring Extn
10 Feb 2021 09:00 AM
RNS
Price Monitoring Extension
05 Feb 2021 04:40 PM
RNS
Second Price Monitoring Extn
05 Feb 2021 04:35 PM
RNS
Price Monitoring Extension
05 Feb 2021 02:06 PM
RNS
Second Price Monitoring Extn
05 Feb 2021 02:01 PM
RNS
Price Monitoring Extension
05 Feb 2021 11:05 AM
RNS
Second Price Monitoring Extn
05 Feb 2021 11:00 AM
RNS
Price Monitoring Extension
03 Feb 2021 02:45 PM
RNS
PDS Phase II Trial Update & Restoration of Trading
02 Feb 2021 07:00 AM
RNS
Suspension of Trading on AIM
25 Jan 2021 07:00 AM
RNS
Issue of Shares, Director/PDMR Shareholding & TVR
04 Jan 2021 10:31 AM
RNS
Holding(s) in Company
21 Dec 2020 02:59 PM
RNS
PDS Announces Publication of Data by Mount Sinai
10 Dec 2020 07:00 AM
RNS
ProAxsis awarded Innovate UK grant
07 Dec 2020 11:05 AM
RNS
Second Price Monitoring Extn
07 Dec 2020 11:00 AM
RNS
Price Monitoring Extension
02 Dec 2020 07:00 AM
RNS
Board changes and Grant of Options
30 Nov 2020 01:56 PM
RNS
EMV Capital leads a £1.28m investment in SageTech
19 Nov 2020 07:00 AM
RNS
ProAxsis appoints DiaPharma as distributor
11 Nov 2020 02:10 PM
RNS
PDS updates on Versamune based COVID-19 vaccine
10 Nov 2020 12:47 PM
RNS
PDS Biotech Initiates VERSATILE-002 Phase 2 Trial
27 Oct 2020 09:46 AM
RNS
PDS Announces Initiation of PDS0101 Phase 2 Trial
16 Oct 2020 07:00 AM
RNS
NetScientific acquires 100% of portfolio company
30 Sep 2020 09:08 AM
RNS
Director/PDMR Shareholding
30 Sep 2020 09:07 AM
RNS
Holding(s) in Company
30 Sep 2020 08:58 AM
RNS
Holding(s) in Company
25 Sep 2020 12:37 PM
RNS
Grant of Options to Director

EMV Capital is a London venture capital company that invests in early-stage, IP-rich, technology and life sciences companies in the UK and internationally.

It is listed on AIM under the ticker EMVC.

EMVC share price launched at 1,620p in 2013.

UK 100

Latest directors dealings